StockData
Verastem, Inc. logo

Verastem, Inc. (VSTM) stock

VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.33−0.53 (-7.73%)

Close on Nov 20, 2026Market cap $573.27MP/E –Yield –

Verastem free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Verastem's free cash flow for the twelve months ending Dec 31, 2024 was -$104.80M. For fiscal 2024 it was -$104.80M. The highest annual figure on record is -$10.16M in fiscal 2011.

Annual free cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$104.80M–
FY2021Dec 31, 2021-$53.70M–
FY2020Dec 31, 2020-$33.54M–
FY2019Dec 31, 2019-$138.53M–
FY2018Dec 31, 2018-$76.02M–
FY2016Dec 31, 2016-$29.52M–
FY2015Dec 31, 2015-$45.77M–
FY2014Dec 31, 2014-$39.33M–
FY2013Dec 31, 2013-$26.36M–
FY2012Dec 31, 2012-$22.91M–
FY2011Dec 31, 2011-$10.16M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024-$25.10M–
Q1 FY2024Jun 30, 2024-$55.91M–
Q4 FY2021Dec 31, 2021-$9.93M–
Q3 FY2021Sep 30, 2021-$10.83M-124.2%
Q2 FY2021Jun 30, 2021-$13.42M–
Q1 FY2021Mar 31, 2021-$19.51M–
Q4 FY2020Dec 31, 2020-$21.70M–
Q3 FY2020Sep 30, 2020$44.74M–
Q4 FY2019Dec 31, 2019-$37.22M–
Q4 FY2018Dec 31, 2018-$19.45M–
Q3 FY2018Sep 30, 2018-$23.13M–
Q2 FY2018Jun 30, 2018-$10.89M–
Q1 FY2018Mar 31, 2018-$22.56M–
Q4 FY2016Dec 31, 2016-$5.95M–

More Verastem figures

See a number that looks wrong?